Pauline Heslop summarises a UK primary care study that shows how emergency hospital admissions for preventable conditions can be reduced in people with learning disabilities who receive annual health checks.
[read the full story...]
Elena Marcus presents a recent study that shows how older Australian men with bipolar disorder have an increased risk of dementia and early death.
[read the full story...]
This Cochrane review of community-based oral health promotion interventions included 38 studies and suggests that interventions combining oral health education with supervised toothbrushing or professional preventive oral care can reduce dental caries in children.
[read the full story...]
Joanne Wallace considers a recent systematic review of exercise in severe mental illness, which focuses on the factors that motivate people to exercise, and the barriers that can prevent physical activity.
[read the full story...]
Kirsten Lawson summarises the UPBEAT-UK programme of research into the relationship between coronary heart disease and depression and anxiety in primary care patients.
[read the full story...]
Dave Steele warms up for the winter triathlon season by reading a new systematic review on the effect of exercise on depressive symptoms in adolescents.
[read the full story...]
Linda Gask writes her debut Mental Elf blog on a recent systematic review, which evaluates healthcare team training programs that aim to improve depression in primary care.
[read the full story...]
Leen Vereenooghe summarises the TOP-COG study (Towards Onset Prevention of COGnitive decline in adults with Down syndrome). This pilot RCT highlights the need to educate people with learning disabilities and their carers about the importance of research participation.
[read the full story...]
Chris Sampson looks at a major new economic study into the return on investment of increased coverage for anxiety and depression treatment.
[read the full story...]
Samei Huda mulls over a recent RCT on the effects of older and newer antipsychotics on quality of life in schizophrenia. The study finds a different result to the 10-year old CUTLASS trial; namely that second generation antipsychotics may be superior to first generation antipsychotics in terms of improving quality of life for people with schizophrenia.
[read the full story...]
